Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747

Br J Pharmacol. 2001 Jan;132(1):47-54. doi: 10.1038/sj.bjp.0703761.

Abstract

1. CS-747 is a novel thienopyridine-type platelet ADP inhibitor which lacks in vitro activity. This study examined pharmacological profiles of R-99224, a hepatic metabolite of CS-747. 2. R-99224 produced a concentration-dependent inhibition of in vitro platelet aggregation in washed human platelets (0.03 - 1 microg ml(-1)), which was relatively specific to ADP compared to collagen and thrombin. 3. R-99224 (0.1 - 3 microg ml(-1)) also elicited a similar inhibition of ADP-induced aggregation in rat platelets. The inhibition by R-99224 (10 microg ml(-1)) persisted even after platelets were washed three times. Intravenous injection of R-99224 (0.1 - 3 mg kg(-1)) to rats resulted in a dose-dependent inhibition of ex vivo ADP-induced platelet aggregation. 4. R-99224 (0.1 - 100 microM) decreased binding of [(3)H]-2-methylthio-ADP ([(3)H]-2-MeS-ADP), a stable ligand for platelet ADP receptors, to washed human platelets. The inhibition by R-99224 reached a plateau at a concentration of 3 microM (1.4 microg ml(-1)), but complete inhibition was not achieved even at the highest concentration used (100 microM). 5. R-99224 (10 microM) in combination with ARL-66096 (0.3 microM), an ATP analogue-type G(i)-linked P2T receptor antagonist, produced no additional inhibition of [(3)H]-2-MeS-ADP binding. In contrast, [(3)H]-2-MeS-ADP binding was completely abolished by R-99224 (10 microM) in combination with A3P5PS (300 microM), a selective P2Y(1) antagonist, suggesting that R-99224 selectively binds to the G(i)-linked P2T receptor. 6. R-99224 (0.01 - 3 microg ml(-1)) inhibited ADP-induced [(125)I]-fibrinogen binding to human platelets in a concentration-dependent manner. R-99224 (0.1 - 1 microg ml(-1)) also inhibited the ADP-induced decrease in cyclic AMP levels in PGE(1)-stimulated platelets, whereas the agent did not affect ADP (10 microM)-induced Ca(2+) mobilization. 7. These findings suggest that R-99224 is a selective and irreversible antagonist of G(i)-linked P2T receptors and that R-99224 is a responsible molecule for in vivo actions of CS-747.

MeSH terms

  • Adenosine Diphosphate / analogs & derivatives*
  • Adenosine Diphosphate / metabolism
  • Adenosine Triphosphate / analogs & derivatives*
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Calcium / metabolism
  • Cyclic AMP / blood
  • Cyclopropanes / therapeutic use*
  • Fibrinogen / metabolism
  • GTP-Binding Protein alpha Subunits, Gi-Go / metabolism*
  • Humans
  • In Vitro Techniques
  • Male
  • Membrane Proteins*
  • Piperazines / metabolism
  • Piperazines / pharmacology*
  • Piperidines / therapeutic use*
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / pharmacology*
  • Prasugrel Hydrochloride
  • Purinergic P2 Receptor Antagonists*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y12
  • Thionucleotides / metabolism
  • Thiophenes / metabolism
  • Thiophenes / pharmacology*

Substances

  • 2-propylthio-D-beta,gamma-difluoromethylene ATP
  • Cyclopropanes
  • Membrane Proteins
  • P2RY12 protein, human
  • P2ry12 protein, rat
  • Piperazines
  • Piperidines
  • Platelet Aggregation Inhibitors
  • Purinergic P2 Receptor Antagonists
  • R-99224
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y12
  • Thionucleotides
  • Thiophenes
  • methylthio-ADP
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • Fibrinogen
  • Cyclic AMP
  • GTP-Binding Protein alpha Subunits, Gi-Go
  • Prasugrel Hydrochloride
  • Calcium